An early-stage research concept exploring reagent-free multi-analyte blood characterisation through multi-domain optical and spectral sensing, combined with an AI fusion inference engine. The most ambitious research direction in the BIQADX portfolio.
The problem we are addressing
Every conventional blood test — from a basic CBC to a comprehensive metabolic panel — requires chemical reagents. Reagents bind to specific analytes, produce measurable signals, and are quantified against calibration curves. This biochemical amplification step is what makes conventional analysers accurate. It is also what makes them expensive, infrastructure-dependent, and fundamentally inaccessible in low-resource settings.
The reagent model imposes irreducible costs: reagent manufacturing, quality control, cold-chain logistics, expiry management, waste disposal, and the safety complexity of working with chemical agents in field conditions. Removing this dependency entirely would represent a qualitative transformation in the economics and accessibility of blood analysis.
Our research approach
SHBC is not designed around a single sensing modality. The concept hypothesis is that no single optical approach can resolve the full complexity of a biological sample — but that multiple orthogonal sensing modalities, fused by a deep-learning AI model trained on large spectroscopic datasets, might produce the analytical resolution required.
The SHBC concept architecture explores four complementary physical sensing domains applied simultaneously to a levitated sample droplet — eliminating contact-surface interference and enabling clean multi-angle measurement. An AI fusion layer is designed to extract analyte-specific information from the combined signal space in a way that individual modalities cannot achieve alone.
Conventional spectroscopic analysis of liquid samples is compromised by cuvette surfaces, container absorption, and sample contact effects. Acoustic or electromagnetic levitation of a small sample droplet eliminates these confounds entirely — the sample is free-floating in air, accessible to optical interrogation from any angle, and free of substrate interference. This is an established scientific technique used in analytical chemistry research. SHBC is exploring its application to clinical blood analysis at a scale and cost that has not previously been attempted.
What it's for
The Spectral Holographic Blood Computer reads many signals from a single drop — with no chemicals and no waiting. A reagent-free desktop diagnostic designed to be affordable enough for every clinic.
Intended deployment
SHBC is a concept-stage exploration of whether the complete analytical story in a drop of whole blood can be read through physical measurement alone — no staining, no labelling, no perishable chemistry. If feasible, it would represent a fundamental change in how blood is analysed.
A desktop instrument designed for settings where reagent supply-chain disruption is a recurring operational risk — where eliminating the consumable eliminates the single largest source of downtime.
A research environment where richer multi-signal data from tiny samples could help teams investigate biology with less sample burden and fewer reagent-dependent workflows.
Why it matters
A breadth of answers from a single sample.
No perishable, costly chemistry to stock or mix.
Insight in minutes, where the patient is.
Engineered to lower the cost of the answer.
A single drop, read completely.
Questions
It is designed to read many signals from a single drop, reagent-free — framed at a high level here, without revealing the underlying mechanism.
Built for clinics and labs that need breadth from one sample, and for the wider mission of reaching communities beyond centralised healthcare.
BIQADX is at a pre-clinical, prototype stage — Spectral Blood Computer is not currently available for commercial sale. We welcome partnership and pilot conversations.